Pharmacia Genotropin
Executive Summary
Pharmacia's human growth hormone brand Genotropin (somatropin) is approved by FDA July 26 for the supplemental indication of long-term treatment of growth failure in children born small for gestational age who do not manifest catch-up growth by age two. Pharmacia estimates that 12,000 children per year would be eligible for therapy